Table 5.
Argentina | Guatemala | Pakistan | Belgaum | |||||||||||||
Treatment | Control | Treatment | Control | Treatment | Control | Treatment | Control | |||||||||
Characteristic | ACS | No ACS | ACS | No ACS | ACS | No ACS | ACS | No ACS | ACS | No ACS | ACS | No ACS | ACS | No ACS | ACS | No ACS |
Deliveries, N | 271 | 1,297 | 163 | 1,551 | 540 | 5,135 | 39 | 3,812 | 1,871 | 5,927 | 125 | 8,186 | 1,743 | 13,228 | 332 | 16,407 |
Stillbirths, N | 5 | 18 | 3 | 24 | 12 | 94 | 0 | 69 | 117 | 271 | 4 | 347 | 80 | 296 | 4 | 377 |
Stillbirths ≥ 20 weeks GA or ≥ 500 g, N (Rate/1000) | 5 (18.5) | 18 (13.9) | 3 (18.4) | 24 (15.5) | 12 (22.2) | 94 (18.3) | 0 (0.0) | 69 (18.1) | 117 (62.5) | 271 (45.7) | 4 (32.0) | 347 (42.4) | 80 (45.9) | 296 (22.4) | 4 (12.0) | 377 (23.0) |
Nagpur | Kenya | Zambia | Total | |||||||||||||
Treatment | Control | Treatment | Control | Treatment | Control | Treatment | Control | |||||||||
Characteristic | ACS | No ACS | ACS | No ACS | ACS | No ACS | ACS | No ACS | ACS | No ACS | ACS | No ACS | ACS | No ACS | ACS | No ACS |
Deliveries, N | 612 | 5,822 | 84 | 6,351 | 178 | 5,708 | 30 | 7,007 | 519 | 3,043 | 15 | 4,550 | 5,734 | 40,160 | 788 | 47,864 |
Stillbirths, N | 36 | 110 | 5 | 164 | 16 | 123 | 5 | 148 | 27 | 62 | 2 | 85 | 293 | 974 | 23 | 1,214 |
Stillbirths ≥ 20 weeks GA or ≥ 500 g, N (Rate/1000) | 36 (58.8) | 110 (18.9) | 5 (59.5) | 164 (25.8) | 16 (89.9) | 123 (21.5) | 5 (166.7) | 148 (21.1) | 27 (52.0) | 62 (20.4) | 2 (133.3) | 85 (18.7) | 293 (51.1) | 974 (24.3) | 23 (29.2) | 1,214 (25.4) |
aData on administration of ACS from the MNH Registry are available for 1,267/1,304 (97.2 %) of stillbirths in the intervention group and 1,237/1,264 (97.9 %) of stillbirths in the control group